Targeting the Par-4 Protein as a Novel Approach in Depression Treatment
Summary Harvard researchers have discovered methods for identifying agents that modulate the interaction between Par-4 and the dopamine D2 receptor (D2DR). The ability to screen for this interaction may provide researchers with the ability to identify specific small molecule inhibitors of this interaction, providing a novel class of depression therapeutics.
Applications A target for the development of treatments for depression. For Further Information Please Contact the Director of Business Development Michal Preminger Email:
[email protected] Telephone: (617) 432-0920
Inventor(s):
Tsai, Li-Huei
Type of Offer:
Licensing
« More Pharmaceutical Patents